We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$475B
AUM Growth
+$26B
Cap. Flow
-$6.36B
Cap. Flow %
-1.34%
Top 10 Hldgs %
16.2%
Holding
2,616
New
108
Increased
1,286
Reduced
995
Closed
102

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.54B
2
VIPS icon
Vipshop
VIPS
+$825M
3
HON icon
Honeywell
HON
+$813M
4
EL icon
Estee Lauder
EL
+$804M
5
GE icon
GE Aerospace
GE
+$787M

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Consumer Discretionary 15.16%
3 Financials 13.98%
4 Technology 12.16%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCI icon
1251
Donaldson
DCI
$11.1B
$11.3M ﹤0.01%
394,825
-4,317
-1% -$127K
PRAA icon
1252
PRA Group
PRAA
$779M
$11.3M ﹤0.01%
325,970
+22,720
+7% +$1.02M
TE
1253
DELISTED
TECO ENERGY INC
TE
$11.3M ﹤0.01%
423,385
-10,200
-2% -$272K
CLCD
1254
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$11.3M ﹤0.01%
1,347,895
-7,940
-0.6% -$41.8K
AXE
1255
DELISTED
Anixter International Inc
AXE
$11.2M ﹤0.01%
185,670
+6,670
+4% +$427K
LM
1256
DELISTED
Legg Mason, Inc.
LM
$11.2M ﹤0.01%
285,430
+120,100
+73% +$5.14M
OREX
1257
DELISTED
Orexigen Therapeutics, Inc.
OREX
$11.2M ﹤0.01%
650,842
+1,670
+0.3% +$39.8K
POLY
1258
DELISTED
Plantronics, Inc.
POLY
$11.2M ﹤0.01%
236,040
+13,290
+6% +$689K
ESNT icon
1259
Essent Group
ESNT
$6.21B
$11M ﹤0.01%
504,510
+20,660
+4% +$501K
ALLT icon
1260
Allot
ALLT
$379M
$10.9M ﹤0.01%
1,866,840
+11,620
+0.6% +$64.2K
NFX
1261
DELISTED
Newfield Exploration
NFX
$10.8M ﹤0.01%
330,640
-670,200
-67% -$25M
HP icon
1262
Helmerich & Payne
HP
$4.42B
$10.8M ﹤0.01%
200,840
-6,423
-3% -$355K
HZNP
1263
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.7M ﹤0.01%
492,682
-26,220
-5% -$510K
LIVN icon
1264
LivaNova
LIVN
$4.52B
$10.7M ﹤0.01%
+179,656
New +$10.9M
TGNA
1265
DELISTED
TEGNA Inc
TGNA
$10.6M ﹤0.01%
648,877
+5,625
+0.9% +$95.1K
ULTA icon
1266
Ulta Beauty
ULTA
$22B
$10.6M ﹤0.01%
57,075
-2,601
-4% -$449K
PPLI
1267
People Inc
PPLI
$2.99B
$10.5M ﹤0.01%
977,954
+163,397
+20% +$1.89M
WLH
1268
DELISTED
WILLIAM LYON HOMES
WLH
$10.5M ﹤0.01%
633,715
+223,915
+55% +$4.21M
LEG icon
1269
Leggett & Platt
LEG
$1.32B
$10.4M ﹤0.01%
247,746
-3,500
-1% -$155K
QLIK
1270
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$10.4M ﹤0.01%
328,646
-1,283,579
-80% -$42.1M
TPVG icon
1271
TriplePoint Venture Growth BDC
TPVG
$219M
$10.4M ﹤0.01%
865,867
-19,100
-2% -$218K
HUBB icon
1272
Hubbell
HUBB
$27B
$10.3M ﹤0.01%
+102,150
New +$10.4M
OMCL icon
1273
Omnicell
OMCL
$1.7B
$10.3M ﹤0.01%
330,710
+28,090
+9% +$829K
SYNH
1274
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$10.2M ﹤0.01%
+211,230
New +$9.4M
KS
1275
DELISTED
KapStone Paper and Pack Corp.
KS
$10.2M ﹤0.01%
450,320
-16,980
-4% -$372K

Similar funds

T. Rowe Price Associates's Q4 2015 Portfolio in Review

As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
  • T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
  • T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
  • T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
  • T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
  • T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.

Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.